Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Elanco Animal Health Incorporated (ELAN) vs Viatris Inc. (VTRS)

Elanco Animal Health Incorporated and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $20.0B against $11.2B — 1.8× the size. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 4.40%. Viatris Inc. has the higher net margin (−2.79% vs −3.96%) and the lower return on invested capital (−0.20% vs 0.51%). Across the 20 metrics below, Viatris Inc. leads on 11 and Elanco Animal Health Incorporated on 9.

Valuation

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.22 1.41 2.25
P/B 1.69 1.45 1.90
Price to free cash flow 31.22 10.97 16.54
EV/EBITDA 18.78 12.22 12.29
EV/Sales 2.89 2.25 2.56
Earnings yield (1.84%) (2.02%) (2.99%)
Free cash flow yield 3.20% 9.11% 0.00%

Profitability

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Gross margin 55.36% 34.83% 53.94%
Operating margin 1.61% (0.59%) 0.00%
Net margin (3.96%) (2.79%) 0.00%
Free cash flow margin 7.55% 12.83% 0.00%
Return on equity (2.98%) (2.75%) (0.40%)
Return on assets (1.46%) (1.12%) (3.32%)
Return on invested capital 0.51% (0.20%) 0.00%

Growth

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 11.95% 4.40% 10.01%
EPS growth (last fiscal year) (169.12%) (466.04%) —
Revenue growth, 5-year CAGR 7.59% 3.66% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.59 0.94 0.05
Current ratio 2.05 1.58 2.31
Net debt to EBITDA 5.00 4.92 0.85

Dividend

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Dividend yield — 4.15% 1.70%
Payout ratio 0.00 0.31 0.00

Size

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Market cap 11.21b 19.99b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack